logo

Kindred Biosciences (KIN)



Trade KIN now with
  Date
  Headline
2/9/2021 8:36:15 AM Kindred Biosciences Appoints Lyndon Lien And Nanxi Liu To Board
12/22/2020 8:38:43 AM Kindred Initiates Pivotal Efficacy Study Of Tirnovetmab Monoclonal Antibody For Canine Atopic Dermatitis
12/21/2020 9:31:54 AM Kindred Report Positive Results From Pilot Field Effectiveness Study For Anti-TNFa Antibody
12/11/2020 8:03:47 AM Elanco Animal Health Enters Agreement With Kindred Biosciences To Acquire Exclusive Global Rights To KIND-030
10/7/2020 8:10:19 AM Kindred Expands Agreement With Vaxart For Manufacture Of Oral Vaccine For COVID-19 And Other Vaccine Candidates
9/16/2020 8:04:50 AM Kindred Biosciences Reports Positive Results From Pivotal Efficacy Study Of KIND-030
5/20/2020 8:00:40 AM Kindred Biosciences Enters Agreement With Vaxart For Manufacture Of Vaxart's Oral Vaccine Candidate For COVID-19
3/24/2020 8:34:35 AM Kindred Biosciences Announces Positive Results From Pilot Field Efficacy Study Of KIND-025
3/16/2020 4:03:38 PM Kindred Biosciences Q4 Loss/share $0.40 Vs. Loss $0.46 Year Ago
12/12/2019 9:08:17 AM Kindred : EU Oks Mirataz 20 Mg/g Transdermal Ointment For Cats Experiencing Poor Appetite And Weight Loss
10/2/2019 7:02:45 AM Kindred Biosciences Announces Closing Of $50 Mln Senior Secured Debt Facility
9/10/2019 7:03:33 AM Kindred Biosciences Awarded Contract By National Cancer Institute In Support Of The PREVENT Cancer Program